Congress Resource Centre    Global Edition Home Contact us		Up to the minute coverage from key international congresses Offering the latest congress news in oncology ! DG Dispatch your speedy delivery of the latest news and highlights direct from medical congresses ... keeping you medically current !  DG Dispatches - Oncology 07/02/2009 Topical Cream Effective Against Cetuximab-Induced Acne-Like Rash: Presented at ESMO-GI 07/02/2009 Two Bevacizumab-Based Combination Regimens Equally Effective in Patients With Metastatic Colorectal Cancer: Presented at ESMO-GI 07/02/2009 90Y Radioembolisation Provides Benefit for Patients With Colorectal Cancer Liver Metastases Who Have Failed Chemotherapy: Presented at ESMO-GI 07/02/2009 Everolimus Is an Effective Treatment Option for Patients With Pancreatic Neuroendocrine Tumours: Presented at ESMO-GI 07/01/2009 FDG-PET Can Help Prevent Unnecessary Surgery in Patients With Colorectal Liver Metastases: Presented at ESMO-GI 07/01/2009 Radiofrequency Ablation With Chemotherapy Improves Progression-Free Survival in Unresectable Colorectal Cancer Liver Metastases: Presented at ESMO-GI 06/29/2009 KRAS Status Predicts Survival to Cetuximab Plus FOLFOX6 in Patients With Metastatic CRC: Presented at ESMO-GI 06/29/2009 Survival Prolonged With FOLFOXIRI Compared With FOLFIRI in Patients With Metastatic Colorectal Cancer: Presented at ESMO-GI 06/26/2009 Adding Cetuximab to Standard Chemotherapy Improves Response Rates in Patients With Nonresectable Colorectal Liver Metastases: Presented at ESMO-GI 06/26/2009 Bevacizumab Plus Chemotherapy Is Safe, Effective for Older Patients With Metastatic Colorectal Cancer: Presented at ESMO-GI 06/26/2009 Sunitinib Significantly Improves Progression-Free Survival in Patients With Advanced Pancreatic Islet Cell Tumours: Presented at ESMO-GI 06/24/2009 Certain Clinical, Ultrasonographic Characteristics Can Assist in Diagnosing Uveal Melanoma: Presented at COS 06/24/2009 Cladribine Is Safe Overall in Patients With Multiple Sclerosis: Presented at ENS 06/23/2009 Incidence of Febrile Neutropenia After Chemotherapy in Hospitalised Patients Appears Lower Than Expected in Canada: Presented at ICC 06/14/2009 Low-Dose Radioactive Iodine Is Efficacious in Patients With Papillary Thyroid Cancer: Presented at ENDO 09 06/11/2009 New Schedule for Chemotherapy Should Be Standard Treatment for Patients With Early Unfavourable Hodgkin's Lymphoma: Presented at EHA 06/10/2009 Adding Bortezomib to Melphalan/Prednisone or Thalidomide/Prednisone Provides Similar Response Rates in Elders With Multiple Myeloma: Presented at EHA 06/10/2009 Histamine Dihydrochloride/IL-2 Immunotherapy Maintains Improvement in Leukaemia-Free Survival in Acute Myeloid Leukaemia: Presented at EHA 06/09/2009 Suboptimal Response of Imatinib 400 mg in Chronic Myeloid Leukaemia Indicates Need for Early Intervention: Presented at EHA 06/09/2009 Significant Survival Benefit From Adding Oblimersen to Fludarabine-Cyclophosphamide Combination Therapy in Relapsed/Refractory Chronic Lymphocytic Leukaemia: Presented at EHA 06/08/2009 Adding Norethandrolone to Postremission Chemotherapy Improves Outcomes in Elders With de Novo AML: Presented at EHA 06/08/2009 Lenalidomide Plus Dexamethasone Offers Rapid, Effective Treatment for Relapsed or Refractory Multiple Myeloma: Presented at EHA 06/06/2009 Bendamustine Provides Benefit Over Chlorambucil for Patients With Chronic Lymphocytic Leukaemia: Presented at EHA 06/06/2009 In Diffuse, Large B-Cell Non-Hodgkin's Lymphoma, R-CHOP14 Is Similar to R-CHOP21: Presented at ASCO 06/06/2009 Adding Thalidomide to Bortezomib, Melphalan, Prednisone Improves Progression-Free Survival in Elders With Multiple Myeloma: Presented at ASCO 06/05/2009 Concurrent Use of Tamoxifen, Antidepressants Associated With Double Risk of Breast Cancer Relapse: Presented at ASCO 06/05/2009 Curative Surgery May Be Unnecessary for Some Patients With Metastatic Colorectal Cancer: Presented at ASCO 06/05/2009 Ixabepilone Plus Bevacizumab Demonstrates Encouraging Activity Relative to Paclitaxel Plus Bevacizumab for Metastatic Breast Cancer: Presented at ASCO 06/04/2009 Delayed Symptom Progression, Better Tolerability Found With Pegylated Liposomal Doxorubicin Plus Carboplatin for Ovarian Cancer: Presented at ASCO 06/04/2009 Personalised Therapeutic Vaccine Prolongs Progression-Free Survival in Patients With Follicular Lymphoma: Presented at ASCO All contents Copyright (c) 2002 P\S\L Consulting Group Inc. All rights reserved.